Figure 1From: Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical studyUnivariate analysis: the prognostic impact of β1 integrin status on disease-specific survival of breast cancer patients (p = 0.002). (Using Kaplan-Meier table followed by log-rank test).Back to article page